Low-Density Lipoprotein Cholesterol Levels on Statins and Cardiovascular Event Risk in Stable Coronary Artery Disease ― An Observation From the REAL-CAD Study ―

• DOI: 10.1253/circj.cj-22-0168
• Publication Date: 2022-09-13T22:11:28Z
• Authors: Toshiaki Toyota; Takeshi Morimoto; Satoshi Iimuro; Retsu Fujita; Hiroshi Iwata; Katsumi Miyauchi; Teruo Inoue; Yoshihisa Nakagawa; Yosuke Nishihata; Hiroyuki Daida; Yukio Ozaki; Satoru Suwa; Ichiro Sakuma; Yutaka Furukawa; Hiroki Shiomi; Hirotoshi Watanabe; Kyohei Yamaji; Naritatsu Saito; Masahiro Natsuaki; Yasuo Ohashi; Masunori Matsuzaki; Ryozo Nagai; Takeshi Kimura
• Keywords: Unstable angina; Pitavastatin; Cardiovascular event; Stroke

The relationship between very low on-treatment low-density lipoprotein cholesterol (LDL-C) level and cardiovascular event risk is still unclear in patients receiving the same doses of statins.